1. Canadian Cancer Society’s Advisory Committee on Cancer Statistics. Canadian cancer statistics 2017. Toronto: Canadian Cancer Society; 2017.
2. Hortobagyi GN, Connolly JL, Edge SB, et al. American Joint Committee on Cancer cancer staging manual. 8th ed. New York: Springer International Publishing; 2017.
3. Sabel M, Collins L. Atypical and lobular carcinoma in situ: high-risk lesions of the breast. In: Chagpar AB, editor. UptoDate; 2017. Retrieved March 23, 2019 from https://www.uptodate.com/contents/atypia-and-lobular-carcinoma-in-situ-high-risk-lesions-of-the-breast .
4. American Society of Breast Surgeons. Consensus guideline on concordance assessment of image-guided breast biopsies and management of borderline or high-risk lesions. 2016. Retrieved from https://www.breastsurgeons.org/about/statements/PDF_Statements/Concordance_and_High%20RiskLesions.pdf .
5. Hartmann LC, Sellers TA, Frost MH, et al. Benign breast disease and the risk of breast cancer. N Engl J Med. 2005;353:229–37.